ANI PHARMACEUTICALS, INC.

Public Equity (NASDAQ)PharmaceuticalsPublicNASDAQ

📍 Princeton, NJ, United States

StreetZero Signal 60

Be the first to signal interest

About ANI PHARMACEUTICALS, INC.

ANI Pharmaceuticals, Inc. is a diversified specialty pharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals. It focuses on niche therapeutic areas including endocrinology, urology, and oncology. The company operates manufacturing facilities and sells products primarily in the United States.

LATEST FUNDINGRule 144

$613K

Announced 2026-10-29

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for ANI PHARMACEUTICALS, INC..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

EMPLOYEES—

FOUNDED—

HQPrinceton, NJ, United States

Industry

Public Equity (NASDAQ)

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Completed $613,120.5 Rule 144 private placement
Public company listed on NASDAQ
Headquartered in Princeton, NJ
Operates in specialty pharmaceuticals sector

Ask StreetZero about ANI PHARMACEUTICALS, INC.

Put our AI to work on this deal.

What is ANI PHARMACEUTICALS, INC.'s value proposition?Who are ANI PHARMACEUTICALS, INC.'s competitors?Why does this raise matter?Summarize ANI PHARMACEUTICALS, INC. for an investor.

Similar companies

Other Public Equity (NASDAQ) deals, ranked by Signal.

Crowdstrike Holdings, Inc.

$141.0M

Paylocity Holding Corporation

$66.0M

BENTLEY SYSTEMS INC

$67.5M

Palo Alto Networks Inc

$201.4M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.